FDA 510(k)

Visible Patient Suite

K-Number: K212896 · 2021-11-05

Decision Date2021-11-05

Product CodeLLZ

Advisory CommitteeRA

DecisionSubstantially Equivalent

Device Summary

Visible Patient Suite is the device name listed in this FDA 510(k) record. The listed applicant is Visible Patient, Sas. It received FDA 510(k) clearance on 2021-11-05 under 510(k) number K212896. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Visible Patient Suite?

Visible Patient Suite is a medical device that received FDA 510(k) clearance on 2021-11-05. The listed applicant is Visible Patient, Sas. The 510(k) number is K212896.

When did Visible Patient Suite receive FDA 510(k) clearance?

Visible Patient Suite received FDA 510(k) clearance on 2021-11-05, under 510(k) number K212896.

Who is the listed applicant for Visible Patient Suite?

The FDA 510(k) record lists Visible Patient, Sas as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Visible Patient Suite?

The FDA product code for Visible Patient Suite is LLZ.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262449AdvaViewADVAHEALTH SOLUTIONS, LLC K261916NeuroQuant PETCortechs Labs, Inc.K260936RadioViewAINeurocareai, Inc. (Dba Savelife.Ai)K260588Cleerly LABSCleerly, Inc.K262462TheraSphere 360™ Y-90 Management PlatformBoston Scientific Corporation K262143ImageGrid StreamVueCandelis, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.